NO147860C - Analogifremgangsmaate for fremstilling av et multivalent antigen-proteinkompleks egnet til blokkering av allergireaksjoner - Google Patents

Analogifremgangsmaate for fremstilling av et multivalent antigen-proteinkompleks egnet til blokkering av allergireaksjoner

Info

Publication number
NO147860C
NO147860C NO773465A NO773465A NO147860C NO 147860 C NO147860 C NO 147860C NO 773465 A NO773465 A NO 773465A NO 773465 A NO773465 A NO 773465A NO 147860 C NO147860 C NO 147860C
Authority
NO
Norway
Prior art keywords
blocking
preparation
protein complex
antigen protein
multivalent antigen
Prior art date
Application number
NO773465A
Other languages
English (en)
Norwegian (no)
Other versions
NO147860B (no
NO773465L (no
Inventor
Arthur Malley
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of NO773465L publication Critical patent/NO773465L/no
Publication of NO147860B publication Critical patent/NO147860B/no
Publication of NO147860C publication Critical patent/NO147860C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/805—Drug, bio-affecting and body treating compositions involving IgE or IgD
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO773465A 1976-10-12 1977-10-11 Analogifremgangsmaate for fremstilling av et multivalent antigen-proteinkompleks egnet til blokkering av allergireaksjoner NO147860C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/731,414 US4140679A (en) 1976-10-12 1976-10-12 Antigen-protein complex for blocking allergic reactions

Publications (3)

Publication Number Publication Date
NO773465L NO773465L (no) 1978-04-13
NO147860B NO147860B (no) 1983-03-21
NO147860C true NO147860C (no) 1983-06-29

Family

ID=24939399

Family Applications (2)

Application Number Title Priority Date Filing Date
NO773465A NO147860C (no) 1976-10-12 1977-10-11 Analogifremgangsmaate for fremstilling av et multivalent antigen-proteinkompleks egnet til blokkering av allergireaksjoner
NO822838A NO822838L (no) 1976-10-12 1982-08-20 Fremgangsmaate for fremstilling av antigen-protein-kompleks for blokkering av allergireaksjoner

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO822838A NO822838L (no) 1976-10-12 1982-08-20 Fremgangsmaate for fremstilling av antigen-protein-kompleks for blokkering av allergireaksjoner

Country Status (17)

Country Link
US (2) US4140679A (ko)
JP (1) JPS5347516A (ko)
AU (1) AU510639B2 (ko)
BE (1) BE859620A (ko)
CA (1) CA1099258A (ko)
CH (1) CH636524A5 (ko)
DE (1) DE2744983A1 (ko)
DK (1) DK448677A (ko)
ES (1) ES463124A1 (ko)
FI (1) FI58501C (ko)
FR (2) FR2382458A1 (ko)
GB (2) GB1552056A (ko)
LU (1) LU78273A1 (ko)
NL (1) NL7711026A (ko)
NO (2) NO147860C (ko)
SE (2) SE427419B (ko)
ZA (1) ZA775742B (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256732A (en) * 1978-08-15 1981-03-17 Research Corporation Modified grass pollen antigens
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
JPS5639022A (en) * 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
WO1981001145A1 (en) * 1979-10-18 1981-04-30 Univ Illinois Hydrolytic enzyme-activatible pro-drugs
US4469677A (en) * 1980-02-19 1984-09-04 Michael J Gabriel Polypeptide active immunosuppressant fraction
JPS57501848A (ko) * 1980-10-08 1982-10-14
FR2502786B1 (fr) * 1981-03-24 1985-06-21 Stallergenes Laboratoire Procede de fixation d'antigenes et d'anticorps sur support de polysaccharides, et utilisation du produit ainsi obtenu pour les dosages immunologiques
US5126131A (en) * 1983-01-24 1992-06-30 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates.
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US6022544A (en) 1983-01-24 2000-02-08 The John Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
SE8303401D0 (sv) * 1983-06-15 1983-06-15 Pharmacia Ab Beredning och dess anvendning
US4702907A (en) * 1983-08-09 1987-10-27 Cornell Research Foundation, Inc. Process for inducing selective immunosuppression of antibodies
US5447722A (en) * 1983-12-12 1995-09-05 University Of Manitoba Method for the suppression of an immune response with antigen-MPEG conjugates in nonsensitized individuals
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4740371A (en) * 1984-09-17 1988-04-26 International Institute Of Cellular And Molecular Pathology Treatment of allergy
US5026545A (en) * 1984-09-17 1991-06-25 Baxter International, Inc. Treatment of allergy and composition therefor
US5543145A (en) * 1984-09-17 1996-08-06 Baxter International, Inc. Pharmaceutical composition and method for the suppression of factor VIII inhibitor production
US4946945A (en) * 1987-06-23 1990-08-07 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
US5116612A (en) * 1987-06-23 1992-05-26 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
US4990336A (en) * 1989-02-08 1991-02-05 Biosearch, Inc. Sustained release dosage form
CA2015515C (en) 1990-01-03 1999-12-07 Jean-Marie Saint-Remy Pharmaceutical compositions containing antigen-antibody complexes and uses therefor
US5126147A (en) * 1990-02-08 1992-06-30 Biosearch, Inc. Sustained release dosage form
US5191066A (en) * 1990-12-07 1993-03-02 Abbott Laboratories Site-specific conjugation of immunoglobulins and detectable labels
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US6656488B2 (en) * 2001-04-11 2003-12-02 Ethicon Endo-Surgery, Inc. Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO132132C (ko) * 1968-10-10 1975-09-24 David George Marsh
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation
GB1578348A (en) * 1976-08-17 1980-11-05 Pharmacia Ab Products and a method for the therapeutic suppression of reaginic antibodies responsible for common allergic

Also Published As

Publication number Publication date
GB1552056A (en) 1979-09-05
NL7711026A (nl) 1978-04-14
FI58501B (fi) 1980-10-31
NO147860B (no) 1983-03-21
GB1552057A (en) 1979-09-05
NO773465L (no) 1978-04-13
BE859620A (fr) 1978-02-01
SE427419B (sv) 1983-04-11
DE2744983A1 (de) 1978-04-13
CH636524A5 (fr) 1983-06-15
US4140679A (en) 1979-02-20
FR2382460B1 (ko) 1982-11-19
SE7711422L (sv) 1978-04-13
AU2915877A (en) 1979-04-05
SE8205313D0 (sv) 1982-09-16
ES463124A1 (es) 1978-07-01
US4158705A (en) 1979-06-19
NO822838L (no) 1978-04-13
ZA775742B (en) 1978-08-30
FR2382458B1 (ko) 1982-11-19
FI58501C (fi) 1981-02-10
JPS5347516A (en) 1978-04-28
LU78273A1 (ko) 1978-01-23
CA1099258A (en) 1981-04-14
FR2382458A1 (fr) 1978-09-29
FI772945A (fi) 1978-04-13
DK448677A (da) 1978-04-13
FR2382460A1 (fr) 1978-09-29
AU510639B2 (en) 1980-07-03
SE8205313L (sv) 1982-09-16

Similar Documents

Publication Publication Date Title
NO147860C (no) Analogifremgangsmaate for fremstilling av et multivalent antigen-proteinkompleks egnet til blokkering av allergireaksjoner
NO145367C (no) Fremgangsmaate for fremstilling av funksjonelt protein
NO148888C (no) Fremgangsmaate til fremstilling av en kromoksydholdig katalysator for alkenpolymerisering og anvendelse av denne katalysator
NO772345L (no) Fremgangsm}te til fremstilling av ren metyl-terti{r-butyleter
DK141967C (da) Analogifremgangsmaade til fremstilling af spirolactoner
NO149586C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider
NO158880C (no) Fremgangsmaate for fremstilling av et spesifikt pattedyrhormon.
DK59778A (da) Fremgangsmaade til fremstilling af antigen og antistof
DK557477A (da) Fremgangsmaade til fremstilling af gammaglobuliner immun-nucleinsyrer og immum-dialysater
SE431800B (sv) Forfarande for framstellning av eventuellt med antigen belagda stabila, lyofiliserbara erytrocyter och anvendningen av dessa belagda erytrocyten som reagens
SE430964B (sv) Forfarande for framstellning av ihaliga kroppar av termoplastmaterial
DK158678C (da) Fremgangsmaade til fremstilling af et hepatitis b kerneantigen og anvendelse af dette antigen til fremstilling af diagnostiske praeparater og vacciner.
NO148921C (no) Analogifremgangsmaate til fremstilling av immunpotenserende peptidderivater.
NO154436C (no) Fremgangsmaate til fremstilling av en sjiktstoffkombinasjon
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NL7704724A (nl) Tumor-antigeen en zijn bereiding.
BE844889A (nl) Ritssluitingelement en inrichting en werkwijze voor het vervaardigen daarvan
NO150888C (no) Fremgangsmaate for fremstilling av et encelle-protein
NO146763C (no) Fremgangsmaate til utvinning av immunoglobulin som er egnet til intravenoes administrering
SE442121B (sv) Analogiforfarande for framstellning av psykofarmakologiskt aktiva peptider
SE7709806L (sv) Forfarande for framstellning av peptider
DK28077A (da) Fremgangsmade til ekstraktion af antigen og anvendelse deraf samt produkter fremstillet deraf
DK143173C (da) Fremgangsmaade til fremstilling af et urinstof-urinstofphosphatholdigt droevtyggerfoder
SE7702124L (sv) Forfarande for atervinning av antimonsulfid
DK162177A (da) Fremgangsmade til fremstilling af bispenicillanoyloxy-alkaner